FDA panel backs first-of-a-kind COVID-19 pill from Merck

A Food and Drug Administration (FDA) panel voted 13-10 that the drug molnupiravir’s benefits outweigh its risks, including potential birth defects if used during pregnancy

from The Hindu - Business